These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6119922)

  • 21. [Role of beta-adrenoceptor antagonists in the control of kindling models in rats].
    Yue W; Zhang F; Wang L; Liu ZT
    Yao Xue Xue Bao; 2000 Dec; 35(12):886-9. PubMed ID: 12567907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Electroencephalography in psychiatry--current status and outlook].
    Herrmann WM; Winterer G
    Nervenarzt; 1996 May; 67(5):348-59. PubMed ID: 9005343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The delayed auditory feedback (DAF) method for inducing stress in experiments with beta-blockers and benzodiazepines.
    Taeuber K; Appel E; Badian M
    Psychopharmacol Bull; 1980 Jul; 16(3):74-5. PubMed ID: 6105692
    [No Abstract]   [Full Text] [Related]  

  • 24. [The neurochemical profile of the septal nucleus accumbens in the anxiolytic action of tranquilizers on different models of anxiety].
    Talalaenko AN; Panfilov VIu; Vozdigan SA; Pokramovich AI; Markova OP; Okhrimenko SV
    Eksp Klin Farmakol; 1997; 60(4):7-9. PubMed ID: 9376765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-adrenergic blockers for anxiety.
    Med Lett Drugs Ther; 1984 Jun; 26(664):61-2. PubMed ID: 6145089
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of the effects of a beta-adrenergic blocker and a benzodiazepine upon the recognition of human facial expressions.
    Zangara A; Blair RJ; Curran HV
    Psychopharmacology (Berl); 2002 Aug; 163(1):36-41. PubMed ID: 12185398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Beta blockers in situational anxiety states].
    Strian F; Möller A
    Dtsch Med Wochenschr; 1987 Jun; 112(25):1015-8. PubMed ID: 2885167
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of extremely low doses of phenazepam on EEG of rats and their behavior in various models of anxiety].
    Voronina TA; Molodavkin GM; Cherniavskaia LI; Seredenin SB; Burlakova EB
    Biull Eksp Biol Med; 1997 Sep; 124(9):308-10. PubMed ID: 9445614
    [No Abstract]   [Full Text] [Related]  

  • 29. Glutamate receptor ligands as anxiolytics.
    Chojnacka-Wójcik E; Kłodzinska A; Pilc A
    Curr Opin Investig Drugs; 2001 Aug; 2(8):1112-9. PubMed ID: 11892923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of calcium channel blockers on animal behavior in tests to study their anxiolytic activity].
    Kozlovskiĭ VL; Prakh'e IV
    Eksp Klin Farmakol; 1995; 58(1):18-20. PubMed ID: 7787686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The validation of animal tests of anxiety--pharmacological implications.
    File SE
    Pol J Pharmacol Pharm; 1984; 36(5):505-12. PubMed ID: 6152493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
    Consoli D; Leggio GM; Mazzola C; Micale V; Drago F
    Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The influence of calcium channel blockers on the effects of anxiogenic preparations].
    Kozlovskiĭ VL
    Patol Fiziol Eksp Ter; 2000; (3):3-4. PubMed ID: 10983469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered response to benzodiazepine anxiolytics in mice lacking GABA B(1) receptors.
    Mombereau C; Kaupmann K; van der Putten H; Cryan JF
    Eur J Pharmacol; 2004 Aug; 497(1):119-20. PubMed ID: 15321743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Kava-kava preparations--alternative anxiolytics].
    Nowakowska E; Ostrowicz A; Chodera A
    Pol Merkur Lekarski; 1998 Mar; 4(21):179-180a. PubMed ID: 9640076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Beta blockers between tremor and vibrato].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1986 Apr; 130(17):765-6. PubMed ID: 2872599
    [No Abstract]   [Full Text] [Related]  

  • 37. Despite similar anxiolytic potential, the 5-hydroxytryptamine 2C receptor antagonist SB-242084 [6-chloro-5-methyl-1-[2-(2-methylpyrid-3-yloxy)-pyrid-5-yl carbamoyl] indoline] and chlordiazepoxide produced differential effects on electroencephalogram power spectra.
    Kantor S; Jakus R; Molnar E; Gyongyosi N; Toth A; Detari L; Bagdy G
    J Pharmacol Exp Ther; 2005 Nov; 315(2):921-30. PubMed ID: 16085759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of persistent anxiety and novel uses for anxiolytics.
    J Clin Psychiatry; 1996; 57 Suppl 7():3-95. PubMed ID: 8690695
    [No Abstract]   [Full Text] [Related]  

  • 39. [The effect of different anxiolytics on the anxiety state occurring in rats after stopping the electrical stimulation of the dorsal hippocampus].
    Beĭer EV; Arushanian EB
    Eksp Klin Farmakol; 1999; 62(5):7-10. PubMed ID: 10572742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triggering of ventricular tachycardia by meteorologic and emotional stress: protective effect of beta-blockers and anxiolytics in men and elderly.
    Culić V; Eterović D; Mirić D; Giunio L; Lukin A; Fabijanić D
    Am J Epidemiol; 2004 Dec; 160(11):1047-58. PubMed ID: 15561984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.